共 34 条
- [11] Leukocyte and Endothelial Activation in a Laboratory Model of Extracorporeal Membrane Oxygenation (ECMO) [J]. Pediatric Research, 2000, 48 : 679 - 684
- [12] The effect of selective phosphopdiesterase type 4 inhibitor on polymorphonuclear leukocyte activation during extracorporeal circulation [J]. 21ST EUROPEAN CONFERENCE ON MICROCIRCULATION, 2000, : 83 - 86
- [14] Effect of Glyceryl Trinitrate on Staphylococcus aureus Growth and Leukocyte Activation during Simulated Extracorporeal Circulation [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2014, 62 (05): : 402 - 408
- [15] COMPLEMENT ACTIVATION BY EXTRACORPOREAL-CIRCULATION - EFFECTS OF PRECOATING A MEMBRANE-OXYGENATOR CIRCUIT WITH HUMAN WHOLE-BLOOD [J]. SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1988, 22 (03): : 251 - 256
- [16] EXPERIMENTAL-MODEL OF EXTRACORPOREAL-CIRCULATION ON EWE FETUS [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1988, 81 (02): : 234 - 234
- [18] Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 118 (03): : 460 - 466
- [19] Platelet activation and degradation in an experimental extracorporeal system. A comparison between a silicone membrane and a hollow-fibre oxygenator [J]. PERFUSION-UK, 1996, 11 (05): : 383 - 388
- [20] PLATELET CONSUMPTION IN CONTROL AND HEPARIN BONDED OXYGENATOR DURING EXTRACORPOREAL-CIRCULATION WITH IN-111 LABELED PLATELETS IN A PIG MODEL [J]. ARTERIOSCLEROSIS, 1990, 10 (05): : A921 - A921